The British Generic Manufacturers Association (BGMA) has welcomed Tim de Gavre as its new chair – a role he will hold for the next two years.
Tim replaces Peter Ballard, who will serve a further year as vice-chair of the association, which is the representative organisation for generic medicine manufacturers in the UK.
A former chair of the British Biosimilars Association (BBA) – the sister association to the BGMA – Tim is head of Sandoz UK. Tim has worked for Sandoz since 2010 holding a series of leadership roles in biosimilars and generics. Prior to joining Sandoz, Tim worked as a consultant at McKinsey & Company and in healthcare venture capital with Frazier Healthcare Ventures.
